Recently, HAS1 and HA stainings were found to correlate with each other in breast carcinoma cells of these tumors, and HAS1 was associated with estrogen receptor negativity, HER2 positivity, high relapse rate, and short overall survival. This evidence concerns the gene ESR1 and breast carcinoma.